A Phase 1 Study to Evaluate the Relative Bioavailability of Octreotide Acetate Tablets(T25) Compared to MYCAPSSA and The Food Effect on Pharmacokinetics Of Octreotide Acetate Tablets(T25) (clinicaltrials.gov) - Aug 25, 2026 - P1 | N=18 | Completed | Sponsor: Triastek (Shanghai) Limited | Not yet recruiting ➔ Completed
Trial completion • Acromegaly • Endocrine Disorders
|